Czechia· CZ-0278852
KARTESADA
A pregabalin product containing pregabalin, registered in Czechia by Egis Pharmaceuticals PLC, Budapešť. The same ATC class is registered in 16 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Pregabalin is registered in 16 of 19 countries.
Countries holding a registration under ATC N02BF02 (pregabalin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 10 of them publish a price we can compare per daily dose
Pregabalin · ATC N02BF02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pregabalin costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.25 in United States to $2.99 in Switzerland — a ×12 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Pregabalin · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.99
- IT Italy$1.59
- US United States$0.25 (acquisition cost)
The record
At a glance
SÚKL (Czech Republic)- Active substance
- PREGABALIN
- Manufacturer
- Egis Pharmaceuticals PLC, Budapešť
- Country
- Czechia (CZ)
- ATC code
- N02BF02
- ATC class
- Pregabalin
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl027885256CZK 2713.77
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
244 interactions on record for pregabalin.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pregabalin · interactions on record
244 records
- 4 severe
- 60 moderate
- 180 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03f92a17-cf5f-4364-9e0f-7ede7756f471 GET /v1/drugs/03f92a17-cf5f-4364-9e0f-7ede7756f471?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS DUR",
"source": "sukl",
"strength": "150MG",
"pack_size": "56",
"substance": "PREGABALIN",
"cz_kod_sukl": "0278852",
"product_type": "CH",
"substance_codes": "15519",
"registration_state": "B",
"registration_number": "21/652/15-C"
}See everything about pregabalin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.